Profile
ABCM VRTX ALNY REGN ARGX SGEN
Company Name Abcam plc Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.52B $101.65B $61.42B $57.97B $46.27B $43.15B
Employees 1.76K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Alan Thomas Hirzel BS, Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
ABCM VRTX ALNY REGN ARGX SGEN
Quant Rating Score 4 1 4 4 3
Quant Rating Buy Strong Sell Buy Buy Neutral
Trading
ABCM VRTX ALNY REGN ARGX SGEN
Last Close $23.99 $391.36 $461.24 $575.06 $752.32 $228.74
High 52 $23.99 $516.74 $482.13 $1150.19 $768 $228.74
Low 52 $23.99 $366.54 $224.58 $482.92 $519.76 $228.74
Price vs. 52 Week High 0 % -24.26 % -4.33 % -50 % -2.04 % 0 %
Price vs. 52 Week Low 0 % 6.77 % 105.38 % 19.08 % 44.74 % 0 %
Total Return
ABCM VRTX ALNY REGN ARGX SGEN
1 Month Return 0 % -0.36 % 2.75 % -0.92 % 15.06 % 0 %
3 Month Return 0 % -11.46 % 49.37 % 12.99 % 39.14 % 0 %
6 Month Return 0 % -23.82 % 82.16 % -15.15 % 22.49 % 0 %
9 Month Return 0 % -16.6 % 87.05 % -22.29 % 17.86 % 0 %
YTD Return 0 % -2.82 % 96.01 % -19.27 % 22.33 % 0 %
1 Year Return 0 % -18.68 % 68.05 % -49.85 % 44.06 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABCM VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) 1.05 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Profitability
ABCM VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM 71.21 % 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM 0.45 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM 0.76 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM 0.8 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 93.62 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 73.44 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM 2.03 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM 27.38 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM - 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 7.04 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM 1.56 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM 195.05 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 31.98 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM 0.3 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM 0.01 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 45.81 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM 19.94 % 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 4.93 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM 27.38 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM - 29.05 -1179.18 15.08 -596.18 -81.26
Price To Operating Cash Flows Ratio TTM 40.46 26.46 -3910.39 12.33 -706.75 -93.1
Price Cash Flow Ratio TTM 40.46 26.46 -3910.39 12.33 -706.75 -93.1
Income Statement (TTM)
ABCM VRTX ALNY REGN ARGX SGEN
Revenue $0.36B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0.27B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 74.79% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $0.04B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -0.04 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
ABCM VRTX ALNY REGN ARGX SGEN
Long Term Debt $0.1B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0.33B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.73B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0.22B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $1.06B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
ABCM VRTX ALNY REGN ARGX SGEN
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $-0.01B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $-0.03B $0B $0B $0B $0B $0B
Operating Cash Flow $0.03B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0.04B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 39.25
AARD Aardvark Therapeutics, Inc. Common Stock 10.69
ABCL AbCellera Biologics Inc. 4.65
ABEO Abeona Therapeutics Inc. 5.7499
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.27
ABPWW 0.046281
ABSI Absci Corporation 2.72
ABUS Arbutus Biopharma Corporation 4.47
ABVC ABVC BioPharma, Inc. 2.92
ABVX Abivax SA American Depositary Shares 82.02
ACAD ACADIA Pharmaceuticals Inc. 24.18
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7982
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.035
ACIU AC Immune SA 2.515
ACLX Arcellx, Inc. 78.27
ETFs With Exposure to ABCM
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 0.40175 142.1
SPDW SPDR Portfolio Developed World ex-US ETF 0.033598 42.76
BIB ProShares Ultra Nasdaq Biotechnology 0.189373 57.475
MNA IQ Merger Arbitrage ETF 6.85 35.643
ONEQ Fidelity Nasdaq Composite Index ETF 0.01 87.565
FPXI First Trust International Equity Opportunities ETF 0.45 59.29
ISCF iShares MSCI Intl Small-Cap Multifactor ETF 0.18111 41.12
MRGR ProShares Merger ETF 3.16608 42.88
FPXE First Trust IPOX Europe Equity Opportunities ETF 0.27 32.345
VINEX Vanguard International Explorer Fund Investor Shares 0.22 20.71
VGHAX Vanguard Health Care Fund Admiral Shares 0.36 75.99
VGHCX Vanguard Health Care Fund Investor Shares 0.36 180.18
BMED BlackRock Future Health ETF 1.68229 26.234
IBBQ Invesco Nasdaq Biotechnology ETF 0.539 23.93
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.48139 5.882
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.53798 6.9725
DFIC Dimensional International Core Equity 2 ETF 0.00052105 32.9065
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 0.53798 6.942
CTRU ARK Transparency ETF 0.96 12.897
Unlock